Performance analysis of Alaunos Therapeutics (TCRT)
Annual Return
Over the past 3 years, TCRT has had an average annual return of -62.83%, underperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, TCRT has had an average annual return of -60.94%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, TCRT has had an average annual return of -40.57%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Aug 24, 2005, TCRT has had an average annual return of -37.06%, underperforming the benchmark SPY, which returned +11.23% annual.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | +0% | -90.00% | -41.18% | -56.41% | -47.30% | +155.17% | -55.38% | -22.62% | -35.38% | +64.56% | +16.18% |
| 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
| +4.62% | -5.80% | -5.48% | +58.70% | +411.11% | -83.64% | -40.86% | +82.35% | -99.49% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +0% | +0% | +0% | ||||||||||
| 2024 | +200% | -33.33% | +0% | -50.00% | +0% | +0% | +0% | +0% | |||||
| 2023 | +20% | -25.00% | +11.11% | -10.00% | -11.11% | +0% | -12.50% | -71.43% | +0% | -50.00% | +0% | +0% | -90.00% |
| 2022 | -0% | -11.76% | -33.33% | -20.00% | +0% | +137.50% | -5.26% | +111.11% | -28.95% | -33.33% | -44.44% | +0% | -41.18% |
| 2021 | +48.72% | +43.10% | -32.53% | -3.57% | -11.11% | -14.58% | -14.63% | -28.57% | +12% | -17.86% | -4.35% | -22.73% | -56.41% |
| 2020 | -16.22% | -22.58% | -20.83% | +15.79% | +4.55% | +10.87% | -9.80% | -4.35% | -11.36% | -15.38% | +33.33% | -11.36% | -47.30% |
| 2019 | +20.69% | +31.43% | +30.43% | +15% | -2.90% | +35.82% | +18.68% | -27.78% | -14.10% | -1.49% | +22.73% | -8.64% | +155.17% |
| 2018 | -4.62% | -6.45% | +5.17% | +8.20% | +16.67% | -38.96% | -14.89% | +15% | +8.70% | -38.00% | +67.74% | -44.23% | -55.38% |
| 2017 | +10.71% | +6.45% | +0% | +11.11% | -17.27% | +6.59% | -11.34% | +16.28% | -4.00% | -23.96% | -2.74% | -8.45% | -22.62% |
Drawdown analysis of Alaunos Therapeutics (TCRT)
The maximum drawdown for the TCRT was -99.99%, occurring on Oct 27, 2023. This drawdown has not yet recovered.
The current TCRT drawdown is -99.99%.
Since Aug 24, 2005 TCRT has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Aug 24, 2005 | 4575 | Oct 27, 2023 | Ongoing | Ongoing | Ongoing |